Otilonium

DB13500InvestigationalSmall molecule

Otilonium is a spasmolytic medication used to treat irritable bowel syndrome (IBS).

Chemical structure of Otilonium
Mechanism
Curator reviewed
Formula / weight
C29H43N2O4 · 483.672 g/mol (avg)

Resolves to

Compound
UNII6330179ARUCAS105360-89-2ChEMBLCHEMBL1433361ChEBI135780
Clinical / RWD
RxNorm32311ATCA03AB06ATCA03CA04
Structure
InChIKeyNQHNLNLJPDMBFN-UHFFFAOYSA-OSMILESCCCCCCCCOC1=CC=CC=C1C(=O)NC1=CC=C(C=C1)C(=O)OCC[N+](C)(CC)CC
Targets
P21452TACR2

What you can answer from here — as of August 30, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,326Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
7Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
71Marketed productsAcross 4 countries and 34 labellers
Sign in
2ATC codesIncluding every combination product, plus 29 drug categories
Sign in
11+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Otilonium, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In